101 related articles for article (PubMed ID: 9306403)
1. Immunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization.
Gerloni M; Baliou WR; Billetta R; Zanetti M
Nat Biotechnol; 1997 Sep; 15(9):876-81. PubMed ID: 9306403
[TBL] [Abstract][Full Text] [Related]
2. VH and VL region structure of antibodies that recognize the (NANP)3 dodecapeptide sequence in the circumsporozoite protein of Plasmodium falciparum.
Anker R; Zavala F; Pollok BA
Eur J Immunol; 1990 Dec; 20(12):2757-61. PubMed ID: 2125276
[TBL] [Abstract][Full Text] [Related]
3. Natural Parasite Exposure Induces Protective Human Anti-Malarial Antibodies.
Triller G; Scally SW; Costa G; Pissarev M; Kreschel C; Bosch A; Marois E; Sack BK; Murugan R; Salman AM; Janse CJ; Khan SM; Kappe SHI; Adegnika AA; Mordmüller B; Levashina EA; Julien JP; Wardemann H
Immunity; 2017 Dec; 47(6):1197-1209.e10. PubMed ID: 29195810
[TBL] [Abstract][Full Text] [Related]
4. Protection against Plasmodium falciparum challenge induced in Aotus monkeys by liver-stage antigen-3-derived long synthetic peptides.
Perlaza BL; Valencia AZ; Zapata C; Castellanos A; Sauzet JP; Blanc C; Cohen J; Arévalo-Herrera M; Corradin G; Herrera S; Druilhe P
Eur J Immunol; 2008 Sep; 38(9):2610-5. PubMed ID: 18792413
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
6. Towards a synthetic malaria vaccine: cyclization of a peptide eliminates the production of parasite-unreactive antibody.
Etlinger HM; Trzeciak A
Philos Trans R Soc Lond B Biol Sci; 1993 Apr; 340(1291):69-72. PubMed ID: 8099745
[TBL] [Abstract][Full Text] [Related]
7. Engineering vaccines with heterologous B and T cell epitopes using immunoglobulin genes.
Xiong S; Gerloni M; Zanetti M
Nat Biotechnol; 1997 Sep; 15(9):882-6. PubMed ID: 9306404
[TBL] [Abstract][Full Text] [Related]
8. Durable immunity and immunologic memory to a parasite antigen induced by somatic transgene immunization.
Gerloni M; Xiong S; Zanetti M
Vaccine; 1998; 16(2-3):293-7. PubMed ID: 9607045
[TBL] [Abstract][Full Text] [Related]
9. A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.
Prieur E; Gilbert SC; Schneider J; Moore AC; Sheu EG; Goonetilleke N; Robson KJ; Hill AV
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):290-5. PubMed ID: 14694197
[TBL] [Abstract][Full Text] [Related]
10. The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.
Del Giudice G; Cooper JA; Merino J; Verdini AS; Pessi A; Togna AR; Engers HD; Corradin G; Lambert PH
J Immunol; 1986 Nov; 137(9):2952-5. PubMed ID: 3531341
[TBL] [Abstract][Full Text] [Related]
11. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
Bergmann ES; Ballou RW; Krzych U
Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys.
Rodríguez A; Mintardjo R; Tax D; Gillissen G; Custers J; Pau MG; Klap J; Santra S; Balachandran H; Letvin NL; Goudsmit J; Radosević K
Vaccine; 2009 Oct; 27(44):6226-33. PubMed ID: 19686691
[TBL] [Abstract][Full Text] [Related]
13. The antibody response in BALB/c mice to the Plasmodium falciparum circumsporozoite repetitive epitope covalently coupled to synthetic lipopeptide adjuvant.
Wiesmüller KH; Jung G; Gillessen D; Loffl C; Bessler WG; Böltz T
Immunology; 1991 Jan; 72(1):109-13. PubMed ID: 1705236
[TBL] [Abstract][Full Text] [Related]
14. Detection of antibodies to Plasmodium falciparum sporozoites by employing synthetic peptides.
Del Giudice G; Biro S; Degrémont AA; Engers HD; Lambert PH; Pessi A; Tougne C; Verdini AS; Weiss N; Tanner M
Parassitologia; 1986; 28(2-3):107-11. PubMed ID: 3332303
[TBL] [Abstract][Full Text] [Related]
15. Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.
Moorthy VS; Imoukhuede EB; Keating S; Pinder M; Webster D; Skinner MA; Gilbert SC; Walraven G; Hill AV
J Infect Dis; 2004 Jun; 189(12):2213-9. PubMed ID: 15181568
[TBL] [Abstract][Full Text] [Related]
16. Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.
Walsh DS; Gettayacamin M; Leitner WW; Lyon JA; Stewart VA; Marit G; Pichyangkul S; Gosi P; Tongtawe P; Kester KE; Holland CA; Kolodny N; Cohen J; Voss G; Ballou WR; Heppner DG
Vaccine; 2006 May; 24(19):4167-78. PubMed ID: 16574282
[TBL] [Abstract][Full Text] [Related]
17. The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.
Bongfen SE; Ntsama PM; Offner S; Smith T; Felger I; Tanner M; Alonso P; Nebie I; Romero JF; Silvie O; Torgler R; Corradin G
Vaccine; 2009 Jan; 27(2):328-35. PubMed ID: 18984024
[TBL] [Abstract][Full Text] [Related]
18. Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design.
Singh S; Soe S; Mejia JP; Roussilhon C; Theisen M; Corradin G; Druilhe P
J Infect Dis; 2004 Sep; 190(5):1010-8. PubMed ID: 15295710
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
[TBL] [Abstract][Full Text] [Related]
20. Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria.
Dodoo D; Theisen M; Kurtzhals JA; Akanmori BD; Koram KA; Jepsen S; Nkrumah FK; Theander TG; Hviid L
J Infect Dis; 2000 Mar; 181(3):1202-5. PubMed ID: 10720556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
